Replies to post #123745 on Biotech Values

[jq1234]

Simponi got CRL for expanding label to include slowing or preventing structural damage from rheumatoid arthritis in certain patients

http://finance.yahoo.com/news/FDA-rejects-new-use-for-JJ-apf-456475643.html?x=0